Cédéric Schaub

ORCID: 0000-0003-0611-0094
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Use and Resistance
  • Pneumonia and Respiratory Infections
  • Antimicrobial Resistance in Staphylococcus
  • Antibiotics Pharmacokinetics and Efficacy
  • Infections and bacterial resistance
  • Bacterial biofilms and quorum sensing

University Hospital of Basel
2020-2022

We investigated the clinical relevance of Dermabacter hominis isolated from samples 108 patients. Polymicrobial growth was evident in 88% specimens. Isolation D. definitive or possible significance only 14% Vancomycin remains drug choice given a penicillin resistance rate 84%.

10.1016/j.diagmicrobio.2020.115118 article EN cc-by-nc-nd Diagnostic Microbiology and Infectious Disease 2020-06-24

Shortening the duration of antibiotic therapy (DAT) for common infectious diseases may be an effective strategy to tackle antimicrobial resistance. Shorter DAT has been proven safe and community-acquired pneumonia (CAP), cellulitis, cholangitis.In a retrospective multicentre quality-control study, medical records 770 patients hospitalized with CAP, cholangitis at three tertiary care hospitals in Switzerland during 2017-2018 were randomly selected. Appropriateness treatment was assessed...

10.1016/j.jgar.2022.12.002 article EN cc-by Journal of Global Antimicrobial Resistance 2022-12-23
Coming Soon ...